Effect of gemcitabine on the expression of a poptosis-related genes in human pancreatic cancer cells
Effect of gemcitabine on the expression of a poptosis-related genes in human pancreatic cancer cells
复制标题
DOI:
10.3748/wjg.v12.i10.1597
复制
发表时间:
2006-03-14
影响因子:
4.3
通讯作者:
Minamoto, Toshinari
中科院分区:
文献类型:
--
作者:
Jiang, Pei-Hong;Motoo, Yoshiharu;Minamoto, Toshinari
AIM: To investigate the expression of genes involved in the gemcitabine-induced cytotoxicity in human pancreatic cancer cells.METHODS: A human pancreatic cancer cell line, PANC-1, was cultured. 1 X 10(4) PANC-1 cells were plated in 96-well microtiter plates. After being incubated for 24 h, gemcitabine was added to the medium at concentrations ranging 2.5 -1 000 mg/L. The AlamarBlue dye method was used for cell growth analysis. DNA fragmentation was quantitatively assayed using a DNA fragmentation enzyme-linked immunosorbent assay (ELISA) kit. PAP and TP53INP1 mRNA expression was determined using the reverse transcription-polymerase chain reaction with semi-quantitative analysis. The expression of GSK-3 beta and phospho-GSK-3 beta proteins was examined with Western blot analysis.RESULTS: The IC50 for the drug after a 48-h exposure to gemcitabine was 16 mg/L. The growth of PANC-1 cells was inhibited by gemcitabine in a concentration-dependent manner (P < 0.0001) and the cell growth was also inhibited throughout the time course (P < 0.0001). The DNA fragmentation rate in the gemcitabine-treated group at 48 h was 44.7 %, whereas it was 25.3 % in the untreated group. The PAP mRNA expression was decreased after being treated with gemcitabine, whereas the TP53INP1 mRNA was increased by the gemcitabine treatment. Western blot analysis showed that phospho-GSK-3 beta(ser9) was induced by the gemcitabine treatment.CONCLUSION: Gemcitabine suppresses PANC-1 cell proliferation and induces apoptosis. Apoptosis is considered to be associated with the inhibition of PAP and GSK-3 beta, and the activation of TP53INP1 and pospho-GSK-3 beta(ser9). (C) 2006 The WJG Press. All rights reserved.